Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Issue Information

Issue Information JUL Y 2019 V O L UME 7 NUMBER 4 P A GES 391–566 ANDROLOGY ANDROLOGY Print ISSN: 2047-2919 | Online ISSN: 2047-2927 | Volume 7, Issue 4, July 2019 Contents Volume 7, Issue 4, July 2019 469 A. Radtke, K.-P. Dieckmann, F. Grobelny, A. Salzbrunn, Editorial C. Oing, W. Schulze and G. Belge 391 E. Rajpert-De Meyts Expression of miRNA-371a-3p in seminal plasma and ejaculate Testicular germ cell cancer: recent developments in biology is associated with sperm concentration and clinical management Review Articles Review Article 475 J. Beyer 394 J. K. Gurney Prognostic factors in metastatic germ-cell cancer The puzzling incidence of testicular cancer in New Zealand: 479 M. Chovanec, J. Mardiak and M. Mego what can we learn? ANDROLOGY Immune mechanisms and possible immune therapy in Original Articles testicular germ cell tumours 402 A. Stang , C. Rusner, B. Trabert, J. W. Oosterhuis, 487 C. Oing, M. A. Skowron, C. Bokemeyer and D. Nettersheim K. A. McGlynn and O. Heidinger Epigenetic treatment combinations to effectively target Incidence of testicular tumor subtypes according to the cisplatin-resistant germ cell tumors-past, present, and future www.wileyonlinelibrary.com/journal/andrology updated WHO classifi cation, North Rhine-Westphalia, considerations Germany, 2008–2013 Original Article 408 M. P. Brandt, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Andrology Wiley

Issue Information

Andrology , Volume 7 (4) – Jul 1, 2019
Download PDF
3 pages

Loading next page...
 
/lp/wiley/issue-information-zwpNjdJph1
Publisher
Wiley
Copyright
Andrology © 2019 American Society of Andrology and European Academy of Andrology
ISSN
2047-2919
eISSN
2047-2927
DOI
10.1111/andr.12674
Publisher site
See Article on Publisher Site

Abstract

JUL Y 2019 V O L UME 7 NUMBER 4 P A GES 391–566 ANDROLOGY ANDROLOGY Print ISSN: 2047-2919 | Online ISSN: 2047-2927 | Volume 7, Issue 4, July 2019 Contents Volume 7, Issue 4, July 2019 469 A. Radtke, K.-P. Dieckmann, F. Grobelny, A. Salzbrunn, Editorial C. Oing, W. Schulze and G. Belge 391 E. Rajpert-De Meyts Expression of miRNA-371a-3p in seminal plasma and ejaculate Testicular germ cell cancer: recent developments in biology is associated with sperm concentration and clinical management Review Articles Review Article 475 J. Beyer 394 J. K. Gurney Prognostic factors in metastatic germ-cell cancer The puzzling incidence of testicular cancer in New Zealand: 479 M. Chovanec, J. Mardiak and M. Mego what can we learn? ANDROLOGY Immune mechanisms and possible immune therapy in Original Articles testicular germ cell tumours 402 A. Stang , C. Rusner, B. Trabert, J. W. Oosterhuis, 487 C. Oing, M. A. Skowron, C. Bokemeyer and D. Nettersheim K. A. McGlynn and O. Heidinger Epigenetic treatment combinations to effectively target Incidence of testicular tumor subtypes according to the cisplatin-resistant germ cell tumors-past, present, and future www.wileyonlinelibrary.com/journal/andrology updated WHO classifi cation, North Rhine-Westphalia, considerations Germany, 2008–2013 Original Article 408 M. P. Brandt,

Journal

Andrology – Wiley

Published: Jul 1, 2019

There are no references for this article.